Application 209903
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | GEL;TOPICAL | 1% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209903-001 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | 1% | GEL / TOPICAL | 2018-08-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A209903-001 | DICLOFENAC SODIUM | 1% | GEL / TOPICAL | 2018-08-03 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A209903-001 | DICLOFENAC SODIUM | 1% | GEL / TOPICAL | 2018-08-03 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209903-001 | DICLOFENAC SODIUM | 1% | GEL / TOPICAL | 2018-08-03 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A209903-001 | DICLOFENAC SODIUM | 1% | GEL / TOPICAL | 2018-08-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A209903-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209903-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A209903-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209903-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209903-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A209903-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A209903-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A209903-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A209903-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A209903-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A209903-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac sodium | DICLOFENAC SODIUM | NuCare Pharmaceuticals, Inc. | 57c83158-f072-6fa2-e063-6394a90aee2c | 2026-07-29 | Warnings | 209903 ANDA209903 |
| Diclofenac sodium | DICLOFENAC SODIUM | Cipla USA Inc. | daf52f5a-1bb7-4808-ab98-483ab9e8cfa0 | 2025-03-11 | Warnings | 209903 ANDA209903 |
| Diclofenac Sodium | DICLOFENAC SODIUM | Quality Care Products, LLC | 12e1f808-9f24-4f6d-b5bc-12ce0059ab7a | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 209903 ANDA209903 |
| Diclofenac Sodium | DICLOFENAC SODIUM | NuCare Pharmaceuticals, Inc. | 200c2800-a703-e138-e063-6394a90acc09 | 2024-08-19 | Boxed warning, Warnings, Adverse reactions | 209903 ANDA209903 |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | 203f96bb-ae63-475c-b7a6-03c0dbc43597 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 209903 ANDA209903 50090-4030 |
| Diclofenac Sodium | DICLOFENAC SODIUM | EXELAN PHARMACEUTICALS INC. | be25c19e-cbea-4f87-a581-9f0d350e5adf | 2024-08-02 | Warnings | 209903 ANDA209903 |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | 51756947-e802-4b4d-883e-fd6f22e9a725 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | 209903 ANDA209903 50090-4020 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16714-976 | Diclofenac sodium | Diclofenac sodium | NorthStar RxLLC | ANDA | Current |
| 16714-976 | Diclofenac sodium | Diclofenac sodium | NorthStar RxLLC | ANDA | Current |
| 50090-4020 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4020 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4020 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4021 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4030 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4030 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-4030 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-5075 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 50090-5077 | Diclofenac Sodium | Diclofenac Sodium | A-S Medication Solutions | ANDA | Current |
| 68788-7433 | Diclofenac Sodium | Diclofenac Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-7433 | Diclofenac Sodium | Diclofenac Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-7433 | Diclofenac Sodium | Diclofenac Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-7433 | Diclofenac Sodium | Diclofenac Sodium | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 69097-524 | Diclofenac Sodium | Diclofenac Sodium | Cipla USA Inc. | ANDA | Current |
| 71335-1226 | Diclofenac Sodium | Diclofenac Sodium | Bryant Ranch Prepack | ANDA | Current |
| 76282-663 | Diclofenac Sodium | Diclofenac Sodium | EXELAN PHARMACEUTICALS INC. | ANDA | Current |
| 76282-663 | Diclofenac Sodium | Diclofenac Sodium | EXELAN PHARMACEUTICALS INC. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79915 | SUPPL | 2024-10-21 |